Clinical Trial Update: The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing tegaserod to placebo for whole gut transit time in chronic constipation and dyspepsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Dyspepsia

Drugs mentioned

• Zelnorm (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Constipation and Dyspepsia | Phase 4 | Status: WITHDRAWN